M. Moehler Et Al. , "Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design," FUTURE ONCOLOGY , vol.15, no.6, pp.567-577, 2019
Moehler, M. Et Al. 2019. Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design. FUTURE ONCOLOGY , vol.15, no.6 , 567-577.
Moehler, M., Ryu, M., Dvorkin, M., Lee, K., COŞKUN, H. Ş., Wong, R., ... Chung, H. C.(2019). Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design. FUTURE ONCOLOGY , vol.15, no.6, 567-577.
Moehler, Markus Et Al. "Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design," FUTURE ONCOLOGY , vol.15, no.6, 567-577, 2019
Moehler, Markus Et Al. "Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design." FUTURE ONCOLOGY , vol.15, no.6, pp.567-577, 2019
Moehler, M. Et Al. (2019) . "Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design." FUTURE ONCOLOGY , vol.15, no.6, pp.567-577.
@article{article, author={Markus Moehler Et Al. }, title={Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design}, journal={FUTURE ONCOLOGY}, year=2019, pages={567-577} }